SOX10 regulates expression of the SH3-domain kinase binding protein 1 (Sh3kbp1) locus in Schwann cells via an alternative promoter

Molecular and Cellular Neuroscience

Volumn 49, Issue 2, 2012, Pages 85-96

  Hodonsky, Chani J ^a   Kleinbrink, Erica L ^a   Charney, Kira N ^a   Prasad, Megana ^b   Bessling, Seneca L ^b   Jones, Erin A ^c   Srinivasan, Rajini ^d   Svaren, John ^d,e   McCallion, Andrew S ^b   Antonellis, Anthony ^a,e  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

CIN85; Comparative sequence analysis; Schwann cells; SH3KBP1; Transcriptional regulation

Indexed keywords

PROTEIN SH3; SH3 DOMAIN KINASE BINDING PROTEIN 1; TRANSCRIPTION FACTOR SOX10; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DEMYELINATING NEUROPATHY; GENE LOCUS; GENE MUTATION; MOUSE; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SCHWANN CELL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; GENE EXPRESSION REGULATION; GENETIC LOCI; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; PROMOTER REGIONS, GENETIC; RATS; SCHWANN CELLS; SOXE TRANSCRIPTION FACTORS; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 83755229011     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2011.10.004     Document Type: Article

References (48)

1. Antonellis A., Bennett W.R., Menheniott T.R., Prasad A.B., Lee-Lin S.Q., Green E.D., Paisley D., Kelsh R.N., Pavan W.J., Ward A. Deletion of long-range sequences at Sox10 compromises developmental expression in a mouse model of Waardenburg-Shah (WS4) syndrome. Hum. Mol. Genet. 2006, 15:259-271.
2. Antonellis A., Dennis M.Y., Burzynski G., Huynh J., Maduro V., Hodonsky C.J., Khajavi M., Szigeti K., Mukkamala S., Bessling S.L., Pavan W.J., McCallion A.S., Lupski J.R., Green E.D. A rare myelin protein zero (MPZ) variant alters enhancer activity in vitro and in vivo. PLoS One 2010, 5:e14346.
3. Antonellis A., Huynh J.L., Lee-Lin S.Q., Vinton R.M., Renaud G., Loftus S.K., Elliot G., Wolfsberg T.G., Green E.D., McCallion A.S., Pavan W.J. Identification of neural crest and glial enhancers at the mouse Sox10 locus through transgenesis in zebrafish. PLoS Genet. 2008, 4:e1000174.
4. Bondurand N., Girard M., Pingault V., Lemort N., Dubourg O., Goossens M. Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10. Hum. Mol. Genet. 2001, 10:2783-2795.
5. Britsch S., Goerich D.E., Riethmacher D., Peirano R.I., Rossner M., Nave K.A., Birchmeier C., Wegner M. The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev. 2001, 15:66-78.
6. Brosamle C., Halpern M.E. Characterization of myelination in the developing zebrafish. Glia 2002, 39:47-57.
7. Buchman V.L., Luke C., Borthwick E.B., Gout I., Ninkina N. Organization of the mouse Ruk locus and expression of isoforms in mouse tissues. Gene 2002, 295:13-17.
8. Elnitski L., Riemer C., Schwartz S., Hardison R., Miller W. PipMaker: a World Wide Web server for genomic sequence alignments. Curr Protoc Bioinformatics Chapter 10, Unit 10 12 2003.
9. Finzsch M., Schreiner S., Kichko T., Reeh P., Tamm E.R., Bosl M.R., Meijer D., Wegner M. Sox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage. J. Cell Biol. 2010, 189:701-712.
10. Fisher S., Grice E.A., Vinton R.M., Bessling S.L., McCallion A.S. Conservation of RET regulatory function from human to zebrafish without sequence similarity. Science 2006, 312:276-279.
11. Fisher S., Grice E.A., Vinton R.M., Bessling S.L., Urasaki A., Kawakami K., McCallion A.S. Evaluating the biological relevance of putative enhancers using Tol2 transposon-mediated transgenesis in zebrafish. Nat. Protoc. 2006, 1:1297-1305.
12. Ghislain J., Charnay P. Control of myelination in Schwann cells: a Krox20 cis-regulatory element integrates Oct6, Brn2 and Sox10 activities. EMBO Rep. 2006, 7:52-58.
13. Gout I., Middleton G., Adu J., Ninkina N.N., Drobot L.B., Filonenko V., Matsuka G., Davies A.M., Waterfield M., Buchman V.L. Negative regulation of PI 3-kinase by Ruk, a novel adaptor protein. EMBO J. 2000, 19:4015-4025.
14. Hogan B., Beddington R., Costantini F., Lacy E. Manipulating the Mouse Embryo: A Laboratory Manual 1994, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 2nd ed.
15. Inoue K., Khajavi M., Ohyama T., Hirabayashi S., Wilson J., Reggin J.D., Mancias P., Butler I.J., Wilkinson M.F., Wegner M., Lupski J.R. Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations. Nat. Genet. 2004, 36:361-369.
16. Inoue K., Tanabe Y., Lupski J.R. Myelin deficiencies in both the central and the peripheral nervous systems associated with a SOX10 mutation. Ann. Neurol. 1999, 46:313-318.
17. Jaegle M., Ghazvini M., Mandemakers W., Piirsoo M., Driegen S., Levavasseur F., Raghoenath S., Grosveld F., Meijer D. The POU proteins Brn-2 and Oct-6 share important functions in Schwann cell development. Genes Dev. 2003, 17:1380-1391.
18. Jang S.W., LeBlanc S.E., Roopra A., Wrabetz L., Svaren J. In vivo detection of Egr2 binding to target genes during peripheral nerve myelination. J. Neurochem. 2006, 98:1678-1687.
19. Jang S.W., Svaren J. Induction of myelin protein zero by early growth response 2 through upstream and intragenic elements. J. Biol. Chem. 2009, 284:20111-20120.
20. Jones E.A., Jang S.W., Mager G.M., Chang L.W., Srinivasan R., Gokey N.G., Ward R.M., Nagarajan R., Svaren J. Interactions of Sox10 and Egr2 in myelin gene regulation. Neuron Glia Biol. 2007, 3:377-387.
21. Jones E.A., Lopez-Anido C., Srinivasan R., Krueger C., Chang L.W., Nagarajan R., Svaren J. Regulation of the PMP22 gene through an intronic enhancer. J. Neurosci. 2011, 31:4242-4250.
22. Jung S.H., Kim S., Chung A.Y., Kim H.T., So J.H., Ryu J., Park H.C., Kim C.H. Visualization of myelination in GFP-transgenic zebrafish. Dev. Dyn. 2010, 239:592-597.
23. Kent W.J., Sugnet C.W., Furey T.S., Roskin K.M., Pringle T.H., Zahler A.M., Haussler D. The human genome browser at UCSC. Genome Res. 2002, 12:996-1006.
24. Kimmel C.B., Ballard W.W., Kimmel S.R., Ullmann B., Schilling T.F. Stages of embryonic development of the zebrafish. Dev. Dyn. 1995, 203:253-310.
25. Kuhlbrodt K., Herbarth B., Sock E., Hermans-Borgmeyer I., Wegner M. Sox10, a novel transcriptional modulator in glial cells. J. Neurosci. 1998, 18:237-250.
26. LeBlanc S.E., Jang S.W., Ward R.M., Wrabetz L., Svaren J. Direct regulation of myelin protein zero expression by the Egr2 transactivator. J. Biol. Chem. 2006, 281:5453-5460.
27. Lee K.E., Nam S., Cho E.A., Seong I., Limb J.K., Lee S., Kim J. Identification of direct regulatory targets of the transcription factor Sox10 based on function and conservation. BMC Genomics 2008, 9:408.
28. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
29. Lyons D.A., Pogoda H.M., Voas M.G., Woods I.G., Diamond B., Nix R., Arana N., Jacobs J., Talbot W.S. erbb3 and erbb2 are essential for schwann cell migration and myelination in zebrafish. Curr. Biol. 2005, 15:513-524.
30. Matys V., Fricke E., Geffers R., Gossling E., Haubrock M., Hehl R., Hornischer K., Karas D., Kel A.E., Kel-Margoulis O.V., Kloos D.U., Land S., Lewicki-Potapov B., Michael H., Munch R., Reuter I., Rotert S., Saxel H., Scheer M., Thiele S., Wingender E. TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 2003, 31:374-378.
31. Mayevska O., Shuvayeva H., Igumentseva N., Havrylov S., Basaraba O., Bobak Y., Barska M., Volod'ko N., Baranska J., Buchman V., Drobot L. Expression of adaptor protein Ruk/CIN85 isoforms in cell lines of various tissue origins and human melanoma. Exp. Oncol. 2006, 28:275-281.
32. Mollaaghababa R., Pavan W.J. The importance of having your SOX on: role of SOX10 in the development of neural crest-derived melanocytes and glia. Oncogene 2003, 22:3024-3034.
33. Newbern J., Birchmeier C. Nrg1/ErbB signaling networks in Schwann cell development and myelination. Semin. Cell Dev. Biol. 2010, 21:922-928.
34. Peirano R.I., Goerich D.E., Riethmacher D., Wegner M. Protein zero gene expression is regulated by the glial transcription factor Sox10. Mol. Cell. Biol. 2000, 20:3198-3209.
35. Peirano R.I., Wegner M. The glial transcription factor Sox10 binds to DNA both as monomer and dimer with different functional consequences. Nucleic Acids Res. 2000, 28:3047-3055.
36. Pingault V., Bondurand N., Kuhlbrodt K., Goerich D.E., Prehu M.O., Puliti A., Herbarth B., Hermans-Borgmeyer I., Legius E., Matthijs G., Amiel J., Lyonnet S., Ceccherini I., Romeo G., Smith J.C., Read A.P., Wegner M., Goossens M. SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat. Genet. 1998, 18:171-173.
37. Reiprich S., Kriesch J., Schreiner S., Wegner M. Activation of Krox20 gene expression by Sox10 in myelinating Schwann cells. J. Neurochem. 2010, 112:744-754.
38. Salazar-Grueso E.F., Kim S., Kim H. Embryonic mouse spinal cord motor neuron hybrid cells. Neuroreport 1991, 2:505-508.
39. Senderek J., Bergmann C., Stendel C., Kirfel J., Verpoorten N., De Jonghe P., Timmerman V., Chrast R., Verheijen M.H., Lemke G., Battaloglu E., Parman Y., Erdem S., Tan E., Topaloglu H., Hahn A., Muller-Felber W., Rizzuto N., Fabrizi G.M., Stuhrmann M., Rudnik-Schoneborn S., Zuchner S., Michael Schroder J., Buchheim E., Straub V., Klepper J., Huehne K., Rautenstrauss B., Buttner R., Nelis E., Zerres K. Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy. Am. J. Hum. Genet. 2003, 73:1106-1119.
40. Soubeyran P., Kowanetz K., Szymkiewicz I., Langdon W.Y., Dikic I. Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature 2002, 416:183-187.
41. Southard-Smith E.M., Kos L., Pavan W.J. Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nat. Genet. 1998, 18:60-64.
42. Stolt C.C., Wegner M. SoxE function in vertebrate nervous system development. Int. J. Biochem. Cell Biol. 2010, 42:437-440.
43. Svaren J., Meijer D. The molecular machinery of myelin gene transcription in Schwann cells. Glia 2008, 56:1541-1551.
44. Take H., Watanabe S., Takeda K., Yu Z.X., Iwata N., Kajigaya S. Cloning and characterization of a novel adaptor protein, CIN85, that interacts with c-Cbl. Biochem. Biophys. Res. Commun. 2000, 268:321-328.
45. Toda K., Small J.A., Goda S., Quarles R.H. Biochemical and cellular properties of three immortalized Schwann cell lines expressing different levels of the myelin-associated glycoprotein. J. Neurochem. 1994, 63:1646-1657.
46. Wegner M., Stolt C.C. From stem cells to neurons and glia: a Soxist's view of neural development. Trends Neurosci. 2005, 28:583-588.
47. Werner T., Hammer A., Wahlbuhl M., Bosl M.R., Wegner M. Multiple conserved regulatory elements with overlapping functions determine Sox10 expression in mouse embryogenesis. Nucleic Acids Res. 2007, 35:6526-6538.
48. Westerfield M. The Zebrafish Book 2000, University of Oregon Press, Eugene, OR.